Selective roles for toll-like receptor (TLR)2 and TLR4 in the regulation of neutrophil activation and life span

被引:277
作者
Sabroe, I
Prince, LR
Jones, EC
Horsburgh, MJ
Foster, SJ
Vogel, SN
Dower, SK
Whyte, MKB
机构
[1] Univ Sheffield, Acad Unit Resp Med, Sect Funct Genom, Div Genom Med, Sheffield S10 2TN, S Yorkshire, England
[2] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England
[3] Univ Sheffield, Dept Microbiol & Immunol, Sheffield S10 2TN, S Yorkshire, England
关键词
D O I
10.4049/jimmunol.170.10.5268
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Neutrophil responses to commercial LPS, a dual Toll-like receptor (TLR)2 and TLR4 activator, are regulated by TLR expression, but are amplified by contaminating monocytes in routine cell preparations. Therefore, we investigated the individual roles of TLR2 and TLR4 in highly purified, monocyte-depleted neutrophil preparations, using selective ligands (TLR2, Pam(3)CysSerLys(4) and staphylococcus aureus peptidoglycan; TLR4, purified LPS). Activation of either TLR2 or TLR4 caused changes in adhesion molecule expression, respiratory burst (alone, and synergistically with fMLP), and IL-8 generation, which was, in part, dependent upon p38 mitogen-activated protein kinase signaling. Neutrophils also. responded to Pam(3)CysSerLys(4) and purified LPS with down-regulation of the chemokine receptor CXCR2 and, to a lesser extent, down-regulation of CXCR1. TLR4 was the principal regulator of neutrophil survival, and TLR2 signals showed relatively less efficacy in preventing constitutive apoptosis over short time courses. TLR4-mediated neutrophil survival depended upon signaling via NF-kappaB and mitogen-activaied protein kinase cascades. Prolonged neutrophil survival required both TLR4 activation and the presence of monocytes. TLR4 activation of monocytes was associated with the release of neutrophil survival factors, which was not evident with TLR2 activation, and TLR2 activation in monocyte/neutrophil cocultures did not prevent late neutrophil apoptosis. Thus, TLRs are important regulators of neutrophil activation and survival, with distinct and separate roles for TLR2 and TLR4 in neutrophil responses. TLR4 signaling presents itself as a pharmacological target that may allow therapeutic modulation of neutrophil survival by direct and indirect mechanisms at sites of inflammation.
引用
收藏
页码:5268 / 5275
页数:8
相关论文
共 61 条
[41]   Chemokines, innate and adaptive immunity, and respiratory disease [J].
Sabroe, I ;
Lloyd, CM ;
Whyte, MKB ;
Dower, SK ;
Williams, TJ ;
Pease, JE .
EUROPEAN RESPIRATORY JOURNAL, 2002, 19 (02) :350-355
[42]   Toll-like receptors: their role in allergy and non-allergic inflammatory disease [J].
Sabroe, I ;
Parker, LC ;
Wilson, AG ;
Whyte, MKB ;
Dower, SK .
CLINICAL AND EXPERIMENTAL ALLERGY, 2002, 32 (07) :984-989
[43]   Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: A critical role for monocytes in leukocyte lipopolysaccharide responses [J].
Sabroe, I ;
Jones, EC ;
Usher, LR ;
Whyte, MKB ;
Dower, SK .
JOURNAL OF IMMUNOLOGY, 2002, 168 (09) :4701-4710
[44]  
Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO
[45]  
2-N
[46]   Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages1 [J].
Schilling, D ;
Thomas, K ;
Nixdorff, K ;
Vogel, SN ;
Fenton, MJ .
JOURNAL OF IMMUNOLOGY, 2002, 169 (10) :5874-5880
[47]   Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes [J].
Sica, A ;
Saccani, A ;
Borsatti, A ;
Power, CA ;
Wells, TNC ;
Luini, W ;
Polentarutti, N ;
Sozzani, S ;
Mantovani, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (05) :969-974
[48]   Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4 [J].
Smiley, ST ;
King, JA ;
Hancock, WW .
JOURNAL OF IMMUNOLOGY, 2001, 167 (05) :2887-2894
[49]   Neutrophil activation by bacterial lipoprotein versus lipopolysaccharide: Differential requirements for serum and CD14 [J].
Soler-Rodriguez, AM ;
Zhang, HW ;
Lichenstein, HS ;
Qureshi, N ;
Niesel, DW ;
Crowe, SE ;
Peterson, JW ;
Klimpel, GR .
JOURNAL OF IMMUNOLOGY, 2000, 164 (05) :2674-2683
[50]  
STRIETER RM, 1992, AM J PATHOL, V141, P397